About the NMVB Research Evaluation Panel (REP)
The NMVB Research Evaluation Panel is composed of experts in the fields of mesothelioma and mesothelioma research, NMVB leadership, and a representative from the patient advocacy community. The Research Evaluation Panel is responsible for reviewing Letters of Intent submitted to the NMVB to determine the scientific merit of a proposed project and assess the ability of the Bank to meet the stated specimen requirements of the researcher. In addition to analyzing the proposed study design, the Research Evaluation Panel will consider whether the research question posed is of sufficient significance to warrant use of NMVB specimens.
NMVB REP Voting Members:
Michele Carbone, MD, PhDProfessor of Pathology
Thoracic Oncology Program, Cancer Research Center of Hawaii
University of Hawaii
 |
Kathy Wiedemer Interim Executive Director The Mesothelioma Applied Research Foundation |
Joseph R. Testa, PhD
Senior Member and Director, Human Genetics Program
Fox Chase Cancer Center
Margaret R. Karagas, PhD
Professor and Section Head, Biostatistics and Epidemiology,
Department of Community and Family Medicine, Dartmouth Medical School
Associate Director, Center for Environmental Health Sciences at Dartmouth
 |
Brooke T. Mossman, PhD Professor of Pathology Director, Environmental Pathology Program University of Vermont, College of Medicine Department of Pathology |
NMVB REP Non-Voting Members:
 |
Michael J. Becich, MD, PhD |
 |
Michael Feldman, MD, PhD |
Jonathan Melamed, MD
Associate Professor. Department of Pathology
New York University
 |
Harvey I. Pass, MD Professor of Surgery and Cardiothoracic Surgery Chief, Division of Thoracic Surgery and Thoracic Oncology Department of Cardiothoracic Surgery Director of Surgical Research NYU School of Medicine and NCI Cancer Center |
Arjun Pennathur, MD
Surgeon
Department of General Thoracic Surgery
UPMC St Margaret's
University of Pittsburgh Medical Center